Publication | Closed Access

Phase II Study of Neoadjuvant Anthracycline-Based Regimens Combined With Nanoparticle Albumin-Bound Paclitaxel and Trastuzumab for Human Epidermal Growth Factor Receptor 2-Positive Operable Breast Cancer

NanomedicineBreast OncologyNanoparticle Albumin-bound PaclitaxelPolymer-drug ConjugateMedicinePharmacologyPhase Ii StudyBreast CancerTumor TargetingOncologyRadiation Oncology